Volume 17, Number 12—December 2011
Letter
Rift Valley and West Nile Virus Antibodies in Camels, North Africa
Table
Results of testing of camels for virus antibodies, by location, age group, and sex of camels examined, North Africa, 2009*
Camel characteristic | No. samples | No. positive for antibody |
|||
---|---|---|---|---|---|
RVFV | WNV | AHSV | RVFV and WNV | ||
Origin | |||||
Tata | 2 | 0 | 0 | 0 | 0 |
Smara-Laayoune | 58 | 13 | 20 | 0 | 11 |
Dakhla | 40 | 2 | 9 | 0 | 1 |
Age group, y | |||||
<1 | 18 | 1 | 1 | 0 | 1 |
1–2 | 25 | 0 | 1 | 0 | 0 |
3–5 | 7 | 1 | 3 | 0 | 1 |
6–10 | 27 | 6 | 12 | 0 | 10 |
>10 | 23 | 7 | 12 | 0 | 0 |
Sex | |||||
M | 71 | 10 | 15 | 0 | 7 |
F | 29 | 5 | 14 | 0 | 5 |
Total | 100 | 15 | 29 | 0 | 12 |
*RVFV, Rift Valley fever virus; WNV, West Nile virus; AHSV, African horse sickness virus.